Friday, April 30, 2021 12:18:24 AM
Breaking News, Best Leronlimab Video Ever, Philippines
BOOM BOOM BOOM
One Hour Ago, Philippines Youtube - Leronlimab FINALLY FINALLY
We have first statement POSITIVE RESULTS the 28 Criticals Given Leronlimab in the Philippines
The Doctor describes details of the positive results with Pres Estrada
THEN HE ADDS: "THAT IS WHAT WE ARE SEEING WITH OUR PATIENTS AS WELL.
"the levels of leronlmab peaks at approx 35 to 50 hrs, right at the peak, the condition of Pres Estrada improved. It is at the peak, that is when we see improvement. THAT'S WHAT WE SEE IN OUR PATIENTS AS WELL"
Asked about the CSP 100,000 vials. How many patients in the Philippines have used leronlimab? He answers: I don't know how many, but it's more than the 28, the improvement is absolutely dramatic!
Doctor: "Gov't Philippine FDA has approved allowance for every hospital in the Philippines to stock enough leronlimab for 100 patients"
BOOM BOOM BOOM
One Hour Ago, Philippines Youtube - Leronlimab FINALLY FINALLY
We have first statement POSITIVE RESULTS the 28 Criticals Given Leronlimab in the Philippines
The Doctor describes details of the positive results with Pres Estrada
THEN HE ADDS: "THAT IS WHAT WE ARE SEEING WITH OUR PATIENTS AS WELL.
"the levels of leronlmab peaks at approx 35 to 50 hrs, right at the peak, the condition of Pres Estrada improved. It is at the peak, that is when we see improvement. THAT'S WHAT WE SEE IN OUR PATIENTS AS WELL"
Asked about the CSP 100,000 vials. How many patients in the Philippines have used leronlimab? He answers: I don't know how many, but it's more than the 28, the improvement is absolutely dramatic!
Doctor: "Gov't Philippine FDA has approved allowance for every hospital in the Philippines to stock enough leronlimab for 100 patients"
Recent CYDY News
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 01:35:02 PM
- CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab • GlobeNewswire Inc. • 03/05/2026 01:30:00 PM
- CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference • GlobeNewswire Inc. • 02/20/2026 01:30:00 PM
- CytoDyn Announces Funding and Initiation of Expanded Access Program for Patients with Triple-negative Breast Cancer • GlobeNewswire Inc. • 01/27/2026 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/09/2026 10:15:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/09/2026 01:30:45 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/22/2025 10:15:23 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/17/2025 05:15:14 AM
- December 2025 Letter to Shareholders • GlobeNewswire Inc. • 12/16/2025 01:30:00 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/10/2025 10:16:32 PM
- CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium • GlobeNewswire Inc. • 12/08/2025 01:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/02/2025 10:15:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:40:20 PM
- CytoDyn Announces Resolution of Class Action Lawsuit • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
